Skip to main content
. 2019 May 28;49(6):469–484. doi: 10.4070/kcj.2019.0136

Figure 2. Event rates per 100 patient years by treatment in all patients and by Asian regions enrolled in PARADIGM-HF.

Figure 2

HF = heart failure; PARADIGM-HF = Prospective comparison of Angiotensin Receptor-neprilysin inhibitor with Angiotensin converting enzyme inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure trial.